Extended adjuvant temozolomide improves survival in a glioblastoma mouse model

被引：0
|
作者：
Wang, Hanxiao [1 ]
Al-Holou, Wajd [1 ]
Heist, Kevin [1 ]
Galban, Craig J. [1 ]
deCarvalho, Ana C. [2 ]
Mikkelsen, Tom [2 ]
Ross, Brian D. [1 ]
Rehemtulla, Alnawaz [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Henry Ford Hosp, Detroit, MI 48202 USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-2061
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2061
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Survival in Patients Receiving Radiotherapy Plus Concomitant and Adjuvant Temozolomide (RCAT) for Glioblastoma (GBM)
    Hargreaves, S. J.
    Williams, M.
    Liu, Z.
    Michalarea, V.
    Woolf, D.
    Wilson, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S281 - S282
  • [22] THE POTENTIAL BENEFIT OF NEOADJUVANT AND EXTENDED-ADJUVANT TEMOZOLOMIDE WITH THE STUPP-REGIMEN IN THE TREATMENT OF GLIOBLASTOMA
    Brown, Ian
    Edwards, Ian T.
    NEURO-ONCOLOGY, 2009, 11 (06) : 947 - 947
  • [23] Effectiveness of adjuvant temozolomide treatment in patients with glioblastoma
    Alnaami, Ibrahim M.
    Al-Nuaimi, Saleem K.
    Senthilselvan, Ambikaipakan
    Murtha, Albert D.
    Walling, Simon
    Mehta, Vivek
    Gourishankar, Sita
    NEUROSCIENCES, 2013, 18 (04) : 349 - 355
  • [24] Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
    Stupp, R
    Mason, WP
    van den Bent, MJ
    Weller, M
    Fisher, B
    Taphoorn, MJB
    Belanger, K
    Brandes, AA
    Marosi, C
    Bogdahn, U
    Curschmann, J
    Janzer, RC
    Ludwin, SK
    Gorlia, T
    Allgeier, A
    Lacombe, D
    Cairncross, JG
    Eisenhauer, E
    Mirimanoff, RO
    Van Den Weyngaert, D
    Kaendler, S
    Krauseneck, P
    Vinolas, N
    Villa, S
    Wurm, RE
    Maillot, MHB
    Spagnolli, F
    Kantor, G
    Malhaire, JP
    Renard, L
    De Witte, O
    Scandolaro, L
    Vecht, CJ
    Maingon, P
    Lutterbach, J
    Kobierska, A
    Bolla, M
    Souchon, R
    Mitine, C
    Tzuk-Shina, T
    Kuten, A
    Haferkamp, G
    de Greve, J
    Priou, F
    Menten, J
    Rutten, I
    Clavere, P
    Malmstrom, A
    Jancar, B
    Newlands, E
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (10): : 987 - 996
  • [25] Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
    Komotar, RJ
    Wilson, DA
    Connolly, ES
    NEUROSURGERY, 2005, 57 (01) : N7 - N8
  • [26] Effect of adjuvant extended temozolamide treatment in survival of patients with glioblastoma multiforme
    Yildirim, Berna Akkus
    Sumbul, Ahmet Taner
    Topkan, Erkan
    Ozdemir, Yurday
    Besen, Ali Ayberk
    Guler, Ozan Cem
    Sedef, Ali Murat
    Onal, Cem
    CUKUROVA MEDICAL JOURNAL, 2018, 43 (03): : 640 - 645
  • [27] Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide
    Stupp, R
    Dietrich, PY
    Kraljevic, SO
    Pica, A
    Maillard, I
    Maeder, P
    Meuli, R
    Janzer, R
    Pizzolato, G
    Miralbell, R
    Porchet, F
    Regli, L
    de Tribolet, N
    Mirimanoff, RO
    Leyvraz, S
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) : 1375 - 1382
  • [28] OUTCOMES AND PREDICTORS OF SURVIVAL FOLLOWING CONCOMITANT AND ADJUVANT TEMOZOLOMIDE WITH RADIOTHERAPY FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Swaminath, A.
    McMillan, W.
    McCarter, H.
    Hirte, H.
    Whitton, A.
    RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S52 - S52
  • [29] Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme
    Kim, Young-Hoon
    Kim, Tackeun
    Joo, Jin-Deok
    Han, Jung Ho
    Kim, Yu Jung
    Kim, In Ah
    Yun, Chang-Ho
    Kim, Chae-Yong
    CANCER, 2015, 121 (17) : 2926 - 2932
  • [30] Updated systematic review and meta-analysis of extended adjuvant temozolomide in patients with newly diagnosed glioblastoma
    Gupta, Tejpal
    Selvarajan, Jeevi Mona Priyadharshni
    Kannan, Sadhana
    Menon, Nandini
    Dasgupta, Archya
    Chatterjee, Abhishek
    NEURO-ONCOLOGY ADVANCES, 2023, 5 (01)
12345